Clinical trial
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
NCT00195637 · National Human Genome Research Institute (NHGRI), NIH · Completed
Key facts
| NCT number | NCT00195637 |
|---|---|
| Title | Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy |
| Official title | Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy |
| Lead sponsor | National Human Genome Research Institute (NHGRI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hereditary Inclusion Body Myopathy |
| Intervention type | Drug |
| Interventions | Immune Globulin |
| Enrollment | 4 |
| Start date | Sep 16, 2005 |
| Primary completion | Jul 3, 2006 |
| Completion | Jul 3, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: